Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-20-021857

Chief Financial Officer bought 67,306 shares at $0.52 ($34,999)

From the SEC's structured data for this filing

Trades in this filing

Hunt Jonathan Robert · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-10-22 Purchase : show line 1 in the form +67,306 $0.52 $34,999 67,306 D
Open-market purchases · 67,306 sh · avg $0.52 · $34,999

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-10-22 Purchase : show line 2 in the form Warrant (right to buy) +33,653 483,653 D
Loading xslF345X03/rdgdoc.xml…